Currently this content is only available in German.
Dieser Inhalt ist momentan nur auf Deutsch verfügbar.

0900 712 712
(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. in the waiting loop by network operator)
0900 712 713

(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. in the waiting loop by network operator)

Notfallnummern

Anmeldung

Sie haben bereits ein Konto?

 

Sie sind noch nicht registriert?

Emergency Contact 24h

0900 712 712

(3.23 CHF / min. from the Swiss landline, possibly additionally 8 Rp. / min. by network operator)

 
 

0900 712 713

(3.12 CHF / min. for calls from prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)


Important Numbers

  • 144   Ambulance
  • 145   Tox Center (Poisoning)
  • 117   Police
  • 118   Fire Department

Kontakt Box

UKBB

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel
Switzerland

T +41 61 704 12 12
F +41 61 704 12 13

Contact

Appointment cancellation
Collection / Reminder 
Patient invoice
Please contact me
Other
empty
Appointment cancellation

For making an appointment or the postponement of an appointment, please contact polyclinic head office +41 61 704 12 20

 
Collection / Reminder 

Collection / Reminder

 
Patient invoice

Patient invoice

 
Please contact me

Please contact me

 
 

How would you like to be contacted?

 
Other

Other

 
empty
 
 
 

Prof. Johannes van den Anker, MD, PhD

Prof. Johannes van den Anker, MD, PhD

Medical Director ASC
Senior Physician Pediatric Pharmacology

 

Personal Data

Date of Birth

May 11, 1957

Nationality

Dutch and American

Family Status

Married, 1 child

Training

1995

Ph.D. Pediatric Pharmacology, Erasmus University, Rotterdam, NL

1991

Specialisation - Neonatal Medicine

1988

Specialisation - Pediatrics

1983

MD, Erasmus University, Rotterdam, NL

Professional Postions

2002-2014

Head of Division of Pediatric Pharmacology and Professor of Pediatrics, Pharmacology & Physiology, Children’s National Medical Center, Washington, DC, USA

1997-2002

Head of Division of Neonatal Medicine and Professor of Pediatrics and Neonatology, Erasmus Medical Center/Sophia Children’s Hospital, Rotterdam, NL

1991-1997

Consultant Neonatal Medicine, Erasmus Medical Center/Sophia Children’s Hospital, Rotterdam, NL

1989-1991

  Fellowship Neonatal Medicine, Erasmus Medical Center/Sophia Children’s Hospital, Rotterdam, NL

1988-1989

Chief Resident, Erasmus Medical Center/Sophia Children’s Hospital, Rotterdam, NL

1984-1988

Clinical training, Pediatrics, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, NL

Acquisition of Research Funds (selection)

Principle investigator: Washington D.C. Collaborative PPRU, NIH/NICHD, 5U10HD045993

Principle investigator: Optimizing Pain Treatment in the Preterm Infant, NIH7NCRR, 5K24RR019729

Principle investigator: Optimizing the use of Morphine in Preterm Infants, NNIH/NICHD,

5RO1HD048689-01A1

Principle investigator: Optimizing the use of Methadone in Newborn Infants, NIH/NIDA, 5K24DA027992

Principle investigator: Metabolism and Toxicity and Efficacy in Longterm Systemic Treatment with Antisense, NIH/NICHD, 5U54HD071601

Co-applicant for FP7-EU grants: TINN, TINN2, NEUROSIS, GRIP

Distinction (selection)

2012

Distinguished Researcher Award from the George Washington University School of Medicine and Health Sciences, Washington, DC, USA

2008

Distinguished Investigator Award from the American College of Clinical Pharmacology

Review Activites

2014-present

Topic Editor Youth Clinical Therapeutics

2013-present

Editor-in-Chief Current Therapeutic Research

2013-present

Associate Editor Journal of Pediatric and Neonatal Individualized Medicine (JPNIM)

2012-present

Section Editor Pediatric Pharmacology of the International Journal of Clinical Pharmacology and Therapeutics

2012-2015

Secretary of the American College of Clinical Pharmacology

2011-present

Associate Editor of Expert Review of Clinical Pharmacology

2011-2017

Member of the American Academy of Pediatrics Committee on Drugs

2011-2017

Member of the American Academy Section on Clinical Pharmacology and Therapeutics

2010-2015

Member of the American College of Clinical Pharmacology

2006-2008

President of the European Society for Development, Perinatal and Pediatric Pharmacology

2005-2008

Member of the Board of Direcotrs of the American Society for Clinical Pharmacology and Therapeutics (ASCPT)

Reviewer

New England Journal of Medicine, Pediatrics, JAMA, Journal of Pediatrics, Clinical Pharmacology and Therapeutics, Clinical Pharmacokinetics, Therapeutic Drug Monitoring, Antimicrobial Agents & Chemotherapy, Critical Care Medicine, American Journal of Obstetrics and Gynecology

Contact

van den Anker, MD, PhD, Johannes

Prof. Johannes van den Anker, MD, PhD

Medical Director ASC Head of Pediatric Pharmacology

 
 

Emergencies

0900 712 712

(3.23 CHF/min. CH-landline, possibly additionally 8 Rp. / min. by network operator)

0900 712 713

(3.12 CHF/min. prepaid cell phones, possibly additionally 8 Rp. / min. by network operator)

Site Map

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
F +41 61 704 12 13

 

Emergency

Contact

University Children’s Hospital Basel
Spitalstrasse 33
4056 Basel / Switzerland

T +41 61 704 12 12
F +41 61 704 12 13

© UKBB, 2018